Hepatitis, Chronic: all 829 studies
Page 6 of 9. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis CNo longer availableNCT02097966
- Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis BCompletedNCT02069678
- Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C PatientsCompletedNCT02065999
- Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)Status unknownNCT02057887Phase 1/2
- Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic MalignancyStatus unknownNCT02056548
- Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal DiseasesWithdrawnNCT02049736Not applicable
- Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT02038387Not applicable
- Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLDCompletedNCT02031913
- Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C InfectionCompletedNCT02027116Phase 1
- Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.CompletedNCT02014571Phase 1
- Patient Self-management and Gene Guided Therapy for Chronic Hepatitis CCompletedNCT02006823
- Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide AnalogsCompletedNCT02005146
- Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B PatientsCompletedNCT01997944Phase 1/2
- Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis CCompletedNCT01980290
- Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve PatientsCompletedNCT01970904Not applicable
- Efficacy Study of Telbivudine in Chronic Hepatitis B PatientsCompletedNCT01958229
- Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In CirrhosisTerminatedNCT01951209Not applicable
- Phase 3 and Extensional Study of BesifovirStatus unknownNCT01937806Phase 3
- A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHBCompletedNCT01935635Phase 1/2
- Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral TherapyCompletedNCT01928511Phase 4
- Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis BStatus unknownNCT01925820Phase 4
- Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis BCompletedNCT01913431Phase 4
- Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide AnaloguesStatus unknownNCT01911156Phase 4
- A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis CCompletedNCT01908335Phase 2
- Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis BStatus unknownNCT01906580Phase 4
- Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis CCompletedNCT01903278Phase 3
- Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis CCompletedNCT01899092Phase 1/2
- Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian PopulationStatus unknownNCT01896609Phase 4
- Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNACompletedNCT01892241Phase 3
- A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis BCompletedNCT01887275Phase 4
- The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg SeroconversionStatus unknownNCT01878565Phase 1/2
- An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)TerminatedNCT01861444
- Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis CCompletedNCT01859962Phase 2
- Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)CompletedNCT01852604Phase 2
- Clinical Investigation of Erlotinib as an HCV Entry InhibitorStatus unknownNCT01835938Phase 1/2
- Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALTStatus unknownNCT01833611Phase 4
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
- Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01829685Phase 4
- Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver FailureCompletedNCT01826760
- Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
- A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedNCT01790100Phase 2
- Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in KoreaStatus unknownNCT01776814
- HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside MaintenanceStatus unknownNCT01769833Phase 3
- Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01760122Phase 3
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedNCT01732367Phase 4
- A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)Status unknownNCT01731301Phase 4
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis CStatus unknownNCT01727934Phase 2
- A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedNCT01726946Phase 2
- Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in ChinaCompletedNCT01726439
- A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C VirusCompletedNCT01724086Phase 2
- Hepatitis C Treatment in Underserved PopulationsStatus unknownNCT01717560Not applicable
- Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to EntecavirCompletedNCT01711567Phase 4
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal DysfunctionCompletedNCT01708889Phase 1
- SIMpill Medication Dispensing Device in the Treatment of HCVWithdrawnNCT01691235
- Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4CompletedNCT01686789Phase 4
- Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive PatientsCompletedNCT01684787Phase 4
- Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis BCompletedNCT01679769
- A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT01671787Phase 1
- Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis cStatus unknownNCT01655966Phase 3
- Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C InfectionStatus unknownNCT01653236Phase 3
- Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382TerminatedNCT01651767Phase 1
- Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis CStatus unknownNCT01649245Phase 4
- Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)WithdrawnNCT01641666Phase 3
- Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis CTerminatedNCT01639547Not applicable
- Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and RibavirinCompletedNCT01634919
- Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis BStatus unknownNCT01627236Not applicable
- Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationTerminatedNCT01627223Phase 4
- BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis CStatus unknownNCT01623336Phase 2/3
- Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus InfectionStatus unknownNCT01607021
- Antiviral Efficacy of Switching to ETV Plus TDFStatus unknownNCT01597934Phase 4
- Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis CCompletedNCT01596517Phase 4
- Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination TherapyStatus unknownNCT01595633Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)WithdrawnNCT01590225Phase 3
- Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)Status unknownNCT01589952Phase 1/2
- Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With EntecavirStatus unknownNCT01588912Phase 4
- A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected PatientsTerminatedNCT01586325Phase 1
- Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C PatientsCompletedNCT01581398Phase 3
- VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis CCompletedNCT01581138Phase 2
- Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)WithdrawnNCT01547312Phase 1
- Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHBCompletedNCT01532843Phase 4
- A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated InterferonCompletedNCT01531166
- Tenofovir in Chronic Hepatitis B With Mild ALT ElevationCompletedNCT01522625Phase 4
- 24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS CWithdrawnNCT01517308Phase 3
- A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated CirrhosisCompletedNCT01516918Phase 2
- An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)CompletedNCT01513941Phase 3
- Keyhole Limpet Hemocyanin in Chronic Hepatitis CCompletedNCT01509391Not applicable
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownNCT01491295Phase 4
- Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B PatientsStatus unknownNCT01487876Phase 2
- Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) InfectionCompletedNCT01480492Not applicable
- HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon TreatedCompletedNCT01471535Not applicable
- The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis CCompletedNCT01464008
- Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C SubjectsStatus unknownNCT01459419Phase 2
- Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)Status unknownNCT01457937Phase 3
- Pharmacogenomic Research in Korean Patients With Hepatitis CCompletedNCT01453244
- Add Vitamin D With Standard of Care for Chronic Hepatitis C PatientsCompletedNCT01439776Phase 4
- Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B PatientsStatus unknownNCT01436539Phase 4
- Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6CompletedNCT01433887Phase 3
- Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis CCompletedNCT01402583